Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.28 | 1e-06 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-06 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-06 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |